Not sure how they have come up with the patient only being on MPL for 9 months.
Cohort 1
Announcement 6 January all 6 patients had been on the for 29 days of dosing
Cohort 2
Announcement 20 February 2023 first patient dosed
Announcement 28 April 2023 MND Trial successfully completes cohort 2
So when did the patient actually pass away if they had only for 9.5 months if they came from cohort 2 and with all patients in this cohort fully doesnt by 6 January 2023 that would mean they must have passed away by end of October 2023.
Or are my maths out or have PAA got it wrong
Ann: Appendix 4C & Quarterly Update, page-47
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.010(4.26%) |
Mkt cap ! $89.08M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 22.0¢ | $170.5K | 749.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34313 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 24444 | 2 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
22.5¢ |
Change
-0.010 ( 6.25 %) |
||||
| Open | High | Low | Volume | ||
| 23.0¢ | 23.0¢ | 22.0¢ | 246904 | ||
| Last updated 15.57pm 14/06/2024 ? | |||||
| PAA (ASX) Chart |